Search

Author/Creator Vourli, Sophia

1. Can bronchial secretion cultures identify the etiologic agent of COVID-19-associated pulmonary aspergillosis in ICU patients? Comparison with a species-specific Aspergillus PCR in serum. (7th December 2022)

Authors:
Siopi, Maria; Antonopoulou, Stavroula; Mantzana, Paraskevi; Georgiou, Panagiota-Christina; Vourli, Sophia; Protonotariou, Efthymia; Vagiakou, Eleni; Skoura, Lemonia; Pournaras, Spyros; Meletiadis, Joseph
Journal:
Medical mycology
Issue:
Volume 61:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetic‐pharmacodynamic modelling of meropenem against VIM‐producingKlebsiella pneumoniaeisolates: clinical implications. Issue 3 (March 2016)

Authors:
Tsala, Marilena; Vourli, Sophia; Kotsakis, Stathis; Daikos, George L.; Tzouvelekis, Leonidas; Zerva, Loukia; Miriagou, Vivi; Meletiadis, Joseph
Journal:
Journal of medical microbiology
Issue:
Volume 65:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates. (30th October 2018)

Authors:
Tsala, Marilena; Vourli, Sophia; Georgiou, Panagiota-Christina; Pournaras, Spyros; Daikos, Geοrge L; Mouton, Johan W; Meletiadis, Joseph
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 74:Number 2(2019)
Page Start:
387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗